Mustang Bio
MBIO • NASDAQ
Mustang Bio is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Manuel Litchman, with a market cap of $5.5M.
Market Cap$5.5M
Employees80.0
CEOManuel Litchman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Mustang Bio FAQ
Common questions about Mustang Bio
Mustang Bio is scheduled to report earnings for Q1 2026 on May 13, 2026.
Mustang Bio has approximately 80 employees.